Delivering drugs through the blood brain barrier

Igor Vivanco, PhD, King's College London, London, UK, describes issues relating to delivering drugs through the blood brain barrier (BBB). Patients with gliomas may have a compromised BBB, allowing treatments to enter the brain, but questions remain in terms of delivering the drug to the necessary area in the correct dosage. Novel strategies such as focused ultrasound and nanoparticles will enable future therapies to cross the BBB. This interview took place at the ESMO Targeted Anticancer Therapies (TAT) Congress 2023 in Paris, France.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.